SEC Filing Details

Document Details

Form
Filing Date
Mar 04, 2024
Document Date
Mar 01, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
RIBEIRO RAMIRO